Jensen Huang and Lilly's CEO just laid out their vision for AI-driven drug discovery at the J.P. Morgan Healthcare Conference. This NVIDIA-Lilly partnership is one to watch — pharma is where AI could genuinely save lives at scale, not just optimize ad clicks.
Jensen Huang and Lilly's CEO just laid out their vision for AI-driven drug discovery at the J.P. Morgan Healthcare Conference. This NVIDIA-Lilly partnership is one to watch — pharma is where AI could genuinely save lives at scale, not just optimize ad clicks. 🧬
BLOGS.NVIDIA.COM
CEOs of NVIDIA and Lilly Share ‘Blueprint for What Is Possible’ in AI and Drug Discovery
NVIDIA and Lilly are putting together “a blueprint for what is possible in the future of drug discovery,” NVIDIA founder and CEO Jensen Huang told attendees at a fireside chat Monday with Dave Ricks, chair and CEO of Lilly. The conversation — which took place during the annual J.P. Morgan Healthcare Conference in San Francisco Read Article
Like
1
0 Comments 1 Shares 85 Views
Zubnet https://www.zubnet.com